Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > EBITDA

Amneal Pharmaceuticals Inc EBITDA Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly EBITDA from 2016 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc EBITDA for the last 12 months ending December 12, 2018 was $413m a 20.82% increase of 86m year over year
  • Amneal Pharmaceuticals Inc Annual EBITDA for 2018 was $413m a 28.63% increase of 118m from 2017
  • Amneal Pharmaceuticals Inc Annual EBITDA for 2017 was $295m a -4.09% decrease of -12m from 2016
  • Amneal Pharmaceuticals Inc Annual EBITDA for 2016 was $307m a 17.63% increase of 54m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX EBITDA Data

12/2018$109m
09/2018$136m
06/2018$103m
03/2018$86m
12/2017$94m
09/2017$72m
06/2017$55m
03/2017$53m
12/2016$102m

Annual AMRX EBITDA Data

2018$413m
2017$295m
2016$307m
2015$253m
2014$243m